Target Price | $67.35 |
Price | $67.72 |
Deviation | 0.55% |
Number of Estimates | 26 |
26 Analysts have issued a price target Mondelez International 2026 . The average Mondelez International target price is $67.35. This is 0.55% lower than the current stock price. The highest price target is $81.00 19.61% , the lowest is $52.00 23.21% . | |
A rating was issued by 31 analysts: 21 Analysts recommend Mondelez International to buy, 9 to hold and 1 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Mondelez International stock has an average upside potential 2026 of 0.55% . Most analysts recommend the Mondelez International stock at Purchase. |
22 Analysts have issued a sales forecast Mondelez International 2025 . The average Mondelez International sales estimate is $37.5b . This is 3.00% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $38.4b 5.30% , the lowest is $37.1b 1.83% .
This results in the following potential growth metrics:
2024 | $36.4b | 1.18% |
---|---|---|
2025 | $37.5b | 3.00% |
2026 | $39.1b | 4.15% |
2027 | $40.7b | 3.99% |
2028 | $41.9b | 3.16% |
2029 | $43.0b | 2.54% |
19 Analysts have issued an Mondelez International EBITDA forecast 2025. The average Mondelez International EBITDA estimate is $6.6b . This is 2.98% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $6.8b 6.15% , the lowest is $6.3b 0.89% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | $6.6b | 3.55% |
---|---|---|
2025 | $6.6b | 0.96% |
2026 | $7.1b | 7.98% |
2027 | $7.6b | 7.02% |
2028 | $8.0b | 5.81% |
2029 | $8.2b | 2.56% |
2024 | 18.20% | 4.67% |
---|---|---|
2025 | 17.50% | 3.84% |
2026 | 18.14% | 3.66% |
2027 | 18.67% | 2.92% |
2028 | 19.15% | 2.57% |
2029 | 19.15% | 0.00% |
10 Mondelez International Analysts have issued a net profit forecast 2025. The average Mondelez International net profit estimate is $3.8b . This is 15.41% lower than the net profit for the last 12 months(TTM). The highest net profit forecast is $3.9b 14.33% , the lowest is $3.8b 16.08% .
This results in the following potential growth metrics and future Net Margins:
2024 | $4.5b | 5.52% |
---|---|---|
2025 | $3.8b | 15.41% |
2026 | $4.3b | 13.41% |
2027 | $4.7b | 9.79% |
2028 | $5.0b | 5.22% |
2029 | $5.3b | 6.07% |
2024 | 12.37% | 6.63% |
---|---|---|
2025 | 10.16% | 17.85% |
2026 | 11.06% | 8.86% |
2027 | 11.68% | 5.61% |
2028 | 11.91% | 1.97% |
2029 | 12.32% | 3.44% |
10 Analysts have issued a Mondelez International forecast for earnings per share. The average Mondelez International EPS is $2.89 . This is 15.50% lower than earnings per share in the financial year 2024. The highest EPS forecast is $2.93 14.33% , the lowest is $2.87 16.08% .
This results in the following potential growth metrics and future valuations:
2024 | $3.42 | 5.52% |
---|---|---|
2025 | $2.89 | 15.50% |
2026 | $3.28 | 13.49% |
2027 | $3.60 | 9.76% |
2028 | $3.79 | 5.28% |
2029 | $4.02 | 6.07% |
Current | 19.77 | 1.20% |
---|---|---|
2025 | 23.41 | 18.41% |
2026 | 20.64 | 11.83% |
2027 | 18.80 | 8.91% |
2028 | 17.87 | 4.95% |
2029 | 16.84 | 5.76% |
Based on analysts' sales estimates for 2025, the Mondelez International stock is valued at an EV/Sales of 2.79 and an P/S ratio of 2.33 .
This results in the following potential growth metrics and future valuations:
Current | 2.87 | 10.59% |
---|---|---|
2025 | 2.79 | 2.75% |
2026 | 2.68 | 3.98% |
2027 | 2.58 | 3.84% |
2028 | 2.50 | 3.06% |
2029 | 2.44 | 2.48% |
Current | 2.40 | 11.19% |
---|---|---|
2025 | 2.33 | 2.91% |
2026 | 2.24 | 3.98% |
2027 | 2.15 | 3.84% |
2028 | 2.09 | 3.06% |
2029 | 2.04 | 2.47% |
Mondelez International...
Analyst | Rating | Action | Date |
---|---|---|---|
Piper Sandler |
Neutral
➜
Neutral
|
Unchanged | Mar 27 2025 |
Morgan Stanley |
➜
Overweight
|
Initiated | Mar 24 2025 |
Mizuho |
Outperform
➜
Outperform
|
Unchanged | Feb 14 2025 |
Barclays |
Overweight
➜
Overweight
|
Unchanged | Feb 06 2025 |
Goldman Sachs |
Buy
➜
Buy
|
Unchanged | Feb 06 2025 |
RBC Capital |
Outperform
➜
Outperform
|
Unchanged | Feb 06 2025 |
Piper Sandler |
Neutral
➜
Neutral
|
Unchanged | Feb 05 2025 |
Analyst Rating | Date |
---|---|
Unchanged
Piper Sandler:
Neutral
➜
Neutral
|
Mar 27 2025 |
Initiated
Morgan Stanley:
➜
Overweight
|
Mar 24 2025 |
Unchanged
Mizuho:
Outperform
➜
Outperform
|
Feb 14 2025 |
Unchanged
Barclays:
Overweight
➜
Overweight
|
Feb 06 2025 |
Unchanged
Goldman Sachs:
Buy
➜
Buy
|
Feb 06 2025 |
Unchanged
RBC Capital:
Outperform
➜
Outperform
|
Feb 06 2025 |
Unchanged
Piper Sandler:
Neutral
➜
Neutral
|
Feb 05 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.